Overview
Drug performance is a vital aspect of new drug development as it draws on interdisciplinary expertise from both pharmaceutics and pharmacokinetics disciplines. It is at the key interface that the discipline of biopharmaceutics has emerged. The past two decades have witnessed considerable advances in biopharmaceutics, particularly with regard to bioavailability/bioequivalence, product quality and regulatory standards of approval. Biopharmaceutics Applications in Drug Development presents readers with step-wise, detail-conscious information to develop quality pharmaceuticals. It is composed of carefully crafted sections introducing key concepts and advances in the areas of dissolution, BA/BE, BCS, IVIC, and product quality, with specific focus on integration of regulatory considerations and case histories highlighting the biopharmaceutics strategies adopted in development of successful drugs.
Full Product Details
Author: Rajesh Krishna ,
Lawrence Yu
Publisher: Springer-Verlag New York Inc.
Imprint: Springer-Verlag New York Inc.
Edition: Softcover reprint of hardcover 1st ed. 2008
Dimensions:
Width: 15.50cm
, Height: 2.10cm
, Length: 23.50cm
Weight: 0.640kg
ISBN: 9781441944344
ISBN 10: 1441944346
Pages: 396
Publication Date: 04 November 2010
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Paperback
Publisher's Status: Active
Availability: In Print
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.
Reviews
From the reviews: The objective of this book is to present `an integrated view linking pharmaceutics and the biological consequences to drug development decision making.' It is written primarily for those who work in the pharmaceutical industry applying biopharmaceutics and pharmacokinetics, or interacting with formulation scientists. The book will also be useful for those in academic and research environments. It could be valuable for students of biopharmaceutics in undergraduate or graduate programs in pharmaceutical science, and should find a role as an innovative pharmD curriculum elective. (Joseph Boullata, Doody's Review Service, August, 2008)
From the reviews: The objective of this book is to present 'an integrated view linking pharmaceutics and the biological consequences to drug development decision making.' It is written primarily for those who work in the pharmaceutical industry applying biopharmaceutics and pharmacokinetics, or interacting with formulation scientists. The book will also be useful for those in academic and research environments. It could be valuable for students of biopharmaceutics in undergraduate or graduate programs in pharmaceutical science, and should find a role as an innovative pharmD curriculum elective. (Joseph Boullata, Doody's Review Service, August, 2008)
From the reviews: The objective of this book is to present `an integrated view linking pharmaceutics and the biological consequences to drug development decision making.' It is written primarily for those who work in the pharmaceutical industry applying biopharmaceutics and pharmacokinetics, or interacting with formulation scientists. The book will also be useful for those in academic and research environments. It could be valuable for students of biopharmaceutics in undergraduate or graduate programs in pharmaceutical science, and should find a role as an innovative pharmD curriculum elective. (Joseph Boullata, Doody's Review Service, August, 2008)
From the reviews: ""The objective of this book is to present ‘an integrated view linking pharmaceutics and the biological consequences to drug development decision making.’ It is written primarily for those who work in the pharmaceutical industry applying biopharmaceutics and pharmacokinetics, or interacting with formulation scientists. The book will also be useful for those in academic and research environments. It could be valuable for students of biopharmaceutics in undergraduate or graduate programs in pharmaceutical science, and should find a role as an innovative pharmD curriculum elective."" (Joseph Boullata, Doody’s Review Service, August, 2008)
"From the reviews: ""The objective of this book is to present ‘an integrated view linking pharmaceutics and the biological consequences to drug development decision making.’ It is written primarily for those who work in the pharmaceutical industry applying biopharmaceutics and pharmacokinetics, or interacting with formulation scientists. The book will also be useful for those in academic and research environments. It could be valuable for students of biopharmaceutics in undergraduate or graduate programs in pharmaceutical science, and should find a role as an innovative pharmD curriculum elective."" (Joseph Boullata, Doody’s Review Service, August, 2008)"
